Non-small cell lung cancer

March 9, 2021 Sarah Howard Channing J. Der, Der lab, Frank McComick, Interview, KRAS, Non-small cell lung cancer, pancreatic cancer, Ras, Ras protein superfamily

Channing Der Interviewed by the Guardian

Channing Der guides the Guardian through the history of the "Undruggable RAS Mutation."

February 28, 2018October 10, 2018 vdoyle099 Channing J. Der, ERK, FDA, melanoma, Merck, Non-small cell lung cancer, Novartis

Merck’s ERK inhibitor shows promise in combo against resistant cancers

by Amirah Al Idrus | Feb 22, 2018 fiercebiotech.com One-fifth of patients in a phase 1 study responded to an investigational ERK inhibitor from Merck, bolstering hopes that this type of drug could be used effectively in combination with other cancer drugs. ERK is a cell signal that is believed to drive the growth of … Continue reading Merck’s ERK inhibitor shows promise in combo against resistant cancers